Boston Scientific's Promising Clinical Trials and Innovative Approaches Justify Buy Rating

TipRanks24minutes ago · Ratings

Boston Scientific Is Maintained at Buy by Canaccord Genuity

Dow JonesDec 10 00:53 · Ratings

Unusual Options Activity: BABA, ADT and Others Attract Market Bets, BABA V/OI Ratio Reaches 120.0

EST Dec 9th Morning Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.

Futu NewsDec 10 00:30

CCORF Maintains Boston Scientific(BSX.US) With Buy Rating, Raises Target Price to $101

Futu NewsDec 9 21:33 · Ratings

Express News | Boston Scientific Corp : Canaccord Genuity Raises Target Price to $101 From $98

BreakingsDec 9 15:38

Boston Scientific (BSX) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Zacks Dec 6 06:15